Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2000
12/26/2000US6165771 Compounds
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165764 Polynucleotides encoding tRNA methyl transferases from Streptococcus pneumoniae
12/26/2000US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides
12/26/2000US6165762 Amino acid sequence of enzyme; drug screening of bactericides and bacteriostats; vaccines; diagnosis of infections
12/26/2000US6165760 Amino acid sequence of polypeptide of the glutamyl transfer rna synthetase family; drug screening of bacteriostats and bactericides; vaccines; diagnosis of infections
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165754 Method of expressing an exogenous nucleic acid
12/26/2000US6165751 HLDAT86 polynucleotides
12/26/2000US6165735 Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof
12/26/2000US6165730 Amino acid sequences of epitopes; for immunoassay diagnosis and immunogens for vaccines
12/26/2000US6165722 Representations of bimolecular interactions
12/26/2000US6165711 Process for disintegrating nucleic acids and preparing biological products of guaranteed quality
12/26/2000US6165502 Protein-lipid vesicles and autogenous vaccine comprising the same
12/26/2000US6165481 Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
12/26/2000US6165478 DNA encoding Chlamydia pneumoniae antigenic polypeptide
12/26/2000US6165477 Mature recombinantly produced protein from eucaryotic cells which is protective against dengue infection, which raises antibodies useful in passive immunization, and which is useful in diagnosis of infection by the virus.
12/26/2000US6165472 Folyl-polyglutamate synthetase (fpgs) of s. pnuemoniae is necessary for a fully functional folate synthesis pathway. having a present benefit of being useful to screen compounds for antibiotic activity.
12/26/2000US6165471 Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents
12/26/2000US6165470 Hybrid macromolecules composed of albumin derivatives coupled to derivatives of the cd4 receptor having a normal or a higher affinity for the hiv-1 virus.
12/26/2000US6165468 Antigenic carbohydrate linked to an immunogenic carrier
12/26/2000US6165467 Stabilized human monoclonal antibody preparation
12/26/2000US6165466 Antagonists of interleukin-15
12/26/2000US6165465 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
12/26/2000US6165464 Monoclonal antibodies directed to the HER2 receptor
12/26/2000US6165463 Dispersible antibody compositions and methods for their preparation and use
12/26/2000US6165462 Sugar kinase
12/26/2000US6165461 Tao protein kinases and methods of use therefor
12/26/2000US6165460 Generation of immune responses to prostate-specific antigen (PSA)
12/26/2000CA2084883C Method for detecting immune dysfunction in asymptomatic aids patients and for predicting organ transplant rejection
12/26/2000CA2018709C Process for removing bacterial endotoxin from gram-negative polysaccharides
12/25/2000CA2276219A1 Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
12/21/2000WO2000077486A2 Compositions and methods for detecting treponema pallidum
12/21/2000WO2000077262A1 Synthetic ligation reassembly in directed evolution
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077227A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy
12/21/2000WO2000077218A1 Vaccine for newcastle disease virus
12/21/2000WO2000077216A2 Porcine circovirus vaccine in recombinant poxvirus
12/21/2000WO2000077210A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077191A1 Tumor necrosis factor related receptor, tr6
12/21/2000WO2000077190A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000WO2000077188A2 Dna pcv vaccine
12/21/2000WO2000077178A1 IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
12/21/2000WO2000077046A1 A male-specific protein homologue involved in histocompatability
12/21/2000WO2000077043A2 Dna vaccines for pets and sport animals
12/21/2000WO2000077041A2 Peptides from decorin binding protein and their uses
12/21/2000WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000076587A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000WO2000076553A1 Use of viral vectors and charged molecules for gene therapy
12/21/2000WO2000076552A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000WO2000076542A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000WO2000076541A1 Pneumococcal surface protein combination vaccine
12/21/2000WO2000076540A2 Streptococcus pneumoniae proteins and vaccines
12/21/2000WO2000076539A2 A method to improve protective immunity induced by polynucleotide vaccines
12/21/2000WO2000076538A1 Feline calicivirus isolated from cat urine and vaccines thereof
12/21/2000WO2000076537A2 Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases
12/21/2000WO2000076534A1 Manufacturing method for intravenous immune globulin and resultant product
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076528A2 Pharmaceutical preparation containing proteins
12/21/2000WO2000076527A2 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
12/21/2000WO2000076476A1 Adjuvant-containing polymerized liposomes for oral, mucosal or intranasal vaccination
12/21/2000WO2000076320A1 Generation of antigen specific t suppressor cells for treatment of rejection
12/21/2000WO2000076319A1 Vaccine formulations and methods for immunizing an individual against shed antigen-specific b cells
12/21/2000WO2000076309A2 Non-human transgenic animals deficient in gas6 function and their use
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000052167A8 Angiopoietin-related protein and nucleic acids
12/21/2000WO2000052056A3 Anti-plasmodium compositions and methods of use
12/21/2000WO2000051647A3 Animal model of allergies
12/21/2000WO2000050443A3 Secreted proteins and uses thereof
12/21/2000WO2000048631A3 Adjuvant and cell maturation agent
12/21/2000WO2000047227A3 Mycobacterium tuberculosis, immunization
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000042068A3 Hiv related peptides
12/21/2000WO2000040701A3 Non-myeloablative tolerogenic treatment
12/21/2000WO2000035950A3 Reagents and methods useful for detecting diseases of the breast
12/21/2000WO2000025588A8 Anti-snoring composition
12/21/2000WO2000020041A8 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
12/21/2000DE19927740A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2379327A1 Pneumococcal surface protein combination vaccine
12/21/2000CA2377431A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000CA2376956A1 Charged compounds facilitate viral transduction of cells
12/21/2000CA2376933A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000CA2376693A1 Immunological control of .beta.-amyloid levels in vivo
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
1 ... 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 ... 1823